124 related articles for article (PubMed ID: 30604632)
1. Interleukin-6 and insulin-like growth factor-1 synergistically promote the progression of NSCLC.
Tang H; Bai Y; Pan G; Wang X; Wei Y; Yang Z; Zhao J
Autoimmunity; 2018 Dec; 51(8):399-407. PubMed ID: 30604632
[TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
3. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
4. Effects of insulin-like growth factor 1 receptor and its inhibitor AG1024 on the progress of lung cancer.
Wei YH; Tang HX; Liao YD; Fu SL; Xu LQ; Chen G; Zhang C; Ju S; Liu ZG; You LK; Yu L; Zhou S
J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):834-841. PubMed ID: 26670433
[TBL] [Abstract][Full Text] [Related]
5. A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer.
Guo XF; Zhu XF; Cao HY; Zhong GS; Li L; Deng BG; Chen P; Wang PZ; Miao QF; Zhen YS
Oncotarget; 2017 Apr; 8(16):27286-27299. PubMed ID: 28460483
[TBL] [Abstract][Full Text] [Related]
6. Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee E; Lee HY
Oncotarget; 2015 Jun; 6(18):16746-56. PubMed ID: 25944691
[TBL] [Abstract][Full Text] [Related]
7. Interaction between epidermal growth factor receptor and interleukin-6 receptor in NSCLC progression.
Yuquan B; Hexiao T; Laiyi W; Gaofeng P; Xuefeng Z; Ming X; Yanhong W; Li Z; Jinping Z
J Cell Biochem; 2019 Jan; 120(1):872-881. PubMed ID: 30132982
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis.
Zhao J; Shi X; Wang T; Ying C; He S; Chen Y
Cell Physiol Biochem; 2017; 43(2):697-704. PubMed ID: 28946136
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice.
Tang H; Liao Y; Xu L; Zhang C; Liu Z; Deng Y; Jiang Z; Fu S; Chen Z; Zhou S
Int J Cancer; 2013 Nov; 133(10):2473-82. PubMed ID: 23649836
[TBL] [Abstract][Full Text] [Related]
10. Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer.
Haura EB; Livingston S; Coppola D
Clin Lung Cancer; 2006 Jan; 7(4):273-5. PubMed ID: 16512982
[TBL] [Abstract][Full Text] [Related]
11. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
Camidge DR; Dziadziuszko R; Hirsch FR
Clin Lung Cancer; 2009 Jul; 10(4):262-72. PubMed ID: 19632946
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Solis L; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee HY
Clin Lung Cancer; 2014 May; 15(3):213-21. PubMed ID: 24485233
[TBL] [Abstract][Full Text] [Related]
14. Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β.
Tang H; Liao Y; Chen G; Xu L; Zhang C; Ju S; Zhou S
Med Oncol; 2012 Dec; 29(4):2640-8. PubMed ID: 22427208
[TBL] [Abstract][Full Text] [Related]
15. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
[TBL] [Abstract][Full Text] [Related]
16. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system.
Al-Shanti N; Saini A; Faulkner SH; Stewart CE
Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025
[TBL] [Abstract][Full Text] [Related]
17. miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor.
Zhao FY; Han J; Chen XW; Wang J; Wang XD; Sun JG; Chen ZT
Int J Mol Med; 2016 Jul; 38(1):183-91. PubMed ID: 27177336
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis.
Lee CY; Jeon JH; Kim HJ; Shin DH; Roh TW; Ahn CM; Chang YS
Korean J Intern Med; 2008 Sep; 23(3):116-20. PubMed ID: 18787363
[TBL] [Abstract][Full Text] [Related]
19. Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors.
Kim JS; Lee SC; Min HY; Park KH; Hyun SY; Kwon SJ; Choi SP; Kim WY; Lee HJ; Lee HY
Cancer Lett; 2015 Jun; 361(2):197-206. PubMed ID: 25721083
[TBL] [Abstract][Full Text] [Related]
20. [Investigational Study of Mesenchymal Stem Cells on Lung Cancer Cell Proliferation and Invasion].
Li M; Wu Y; Liu R; Guo L; Xu T; Chen J; Xu S
Zhongguo Fei Ai Za Zhi; 2015 Nov; 18(11):674-9. PubMed ID: 26582222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]